Gland Pharma Walk In Interview 2022: M.Sc., B.Pharmacy for QC – Chemist At Visakhapatnam. Gland Pharma Notification full details below..Interested and eligible candidates can attend interview on scheduled time and venue.
Vacancy details:
- Post Name: QC – Chemist
- Qualification: M.Sc., B.Pharmacy
- Experienced:0 to 5 years
- Salary:₹ 2,00,000 – 4,00,000 P.A.
Job Description: Gland Pharma Hiring For QC – Chemist !
Important Details :
- Location: Visakhapatnam
- Date: :25th July 2022
- Time:–9.30 AM – 11.00 AM.
- Venue:BLOCK – C PHASE – i, VSEZ, DUVVADA, Visakhapatnam, Andhra Pradesh, India
- Contact – Hemasundar ( 08912747657 )
- Post of date:23/07/2022
- Selection Process: The selection will be on the basis of Interview.
Job description.
Roles and Responsibilities
1.Preparation of Standard Operating Procedures, General Test Procedures, Specifications and Standard Test Procedures.
2.Analysis of In process Samples, Finished, Raw Materials and Stability Samples.
3.Validation and Verification of Methods.
4.Calibration of Instruments.
5.Reviewing of Analytical Data.
6.Inform OOS, OOT and OOC to Supervisor.
7.Preparation and Review of COAs.
8.Preparation of Protocols and Reports.
9.Maintain Online Entries of Reference / Working Standards, Column Log Books, Instrument Log Books.
10.Maintain Related Raw Data and Log Books.
11.Maintain Good Laboratory Practices.
12.Maintain Good Documentation Practices.
13.Maintain Hygienic Conditions and Following Dress Code in QC laboratory.
14.Verification of Raw Data, Log Books and Reports.
About Company:
Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets. We operate primarily under a business to business (B2B) model and have an excellent track record in the development, manufacturing and marketing of complex injectables.
Leave a Reply
View Comments